PYC Therapeutics Limited Price (PYC.AX)

Stock Price

Low: Year Low
High: Year High

Market Cap

Fetching Data...

Enterprise Value

Fetching Data...

Fetching Data...

Shares Outstanding

3,935,910,623

(21.1491)%

Income Statement Summary

Revenue
Cost of Revenue
Gross Profit
Operating Expenses
Operating Income
Other Expenses
Net Income
news-img
PYC Therapeutics Limited
news-img

Income Statement

PYC Therapeutics Limited

Currency: AUD

YEAR 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Revenue
Revenue 52.56k

+0%

0.00

+0%

275.39k

+0%

90.75k

-67%

1.27M

+1,305%

596.26k

-53%

2.36M

+296%

1.92M

-19%

711.89k

-63%

739.39k

+4%

829.12k

+12%

1.08k

-100%

2.76M

+256,660%

48.46k

-98%

0.00

+0%

2.40M

+0%

3.07M

+28%

16.04M

+422%

15.81M

-1%

22.06M

+40%

Cost of Revenue
Cost of Revenue 0.00 137.23k 272.50k 0.00 0.00 0.00 0.00 0.00 3.27M 3.62M 3.58M 122.12k 4.67M 81.30k 130.56k 547.11k 622.36k 839.51k 882.05k 0.00
Gross Profit
Gross Profit 52.56k

+0%

-137,232.00

-361%

2.89k

-102%

90.75k

+3,041%

1.27M

+1,305%

596.26k

-53%

2.36M

+296%

1.92M

-19%

-2,554,845.00

-233%

-2,880,062.00

+13%

-2,749,331.00

-5%

-121,039.00

-96%

-1,909,271.00

+1,477%

-32,838.00

-98%

-130,556.00

+298%

1.85M

-1,516%

2.45M

+33%

15.20M

+520%

14.92M

-2%

22.06M

+48%

Gross Profit Ratio (1.00%) (0.00%) (0.01%) (1.00%) (1.00%) (1.00%) (1.00%) (1.00%) (-3.59%) (-3.90%) (-3.32%) (-112.49%) (-0.69%) (-0.68%) (0.00%) (0.77%) (0.80%) (0.95%) (0.94%) (1.00%)
Operating Expenses
Research and Development 407.78k 1.38M 0.00 2.28M 0.00 0.00 0.00 0.00 4.04M 4.18M 4.12M 4.86M 4.67M 6.96M 4.51M 5.88M 14.00M 24.03M 35.15M 56.41M
General and Administrative 1.26M 1.59M 1.91M 2.02M 1.35M 1.36M 1.53M 1.39M 1.55M 433.96k 541.46k 903.76k 1.04M 1.16M 1.83M 3.82M 7.83M 6.30M 4.09M 4.51M
Selling, General & Admin... 1.26M 1.59M 1.91M 2.02M 1.35M 1.36M 1.53M 1.39M 1.55M 1.80M 1.86M 973.56k 1.85M 2.72M 2.46M 3.28M 7.21M 5.34M 3.14M 4.51M
Selling & Marketing Exp... 0.00 19.93k 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1.37M 1.31M 1.11M 814.49k 1.42M 1.82M -541,472.00 -622,362.00 -960,358.00 -956,086.00 0.00
Depreciation and Amortiz... 42.30k 18.14k 26.28k 49.48k 114.03k 66.94k 154.54k 196.30k 274.17k 214.26k 212.24k 122.12k 55.26k 81.30k 130.56k 547.11k 622.36k 839.51k 882.05k 1.07M
Other Expenses 127.42k 33.77k 605.47k 783.62k 3.63M 3.90M 4.55M 4.60M 711.89k 47.24k 65.74k 1.08k 2.76M 48.46k 250.00 62.50k 3.13M 15.92M 15.75M 0.00
Total Operating Expenses 1.79M 3.94M 4.70M 5.66M 4.98M 5.26M 6.08M 5.98M 6.10M 2.26M 2.28M 5.83M 2.34M 9.69M 6.97M 9.15M 21.21M 29.37M 38.28M 60.92M
Cost and Exponses 1.79M 4.08M 4.97M 5.66M 4.98M 5.26M 6.08M 5.98M 6.10M 5.88M 5.86M 5.95M 7.01M 9.77M 7.10M 9.70M 21.83M 30.21M 39.16M 60.92M
Operating Income
Operating Income -1,740,919.00

+0%

-4,076,800.00

+134%

-4,695,773.00

+15%

-5,573,815.00

+19%

-3,702,574.00

-34%

-4,664,483.00

+26%

-3,717,689.00

-20%

-4,066,070.00

+9%

-6,104,530.00

+50%

-5,136,138.00

-16%

-5,033,278.00

-2%

-5,950,980.00

+18%

-4,251,606.00

-29%

-9,768,150.00

+130%

-7,102,100.00

-27%

-9,701,850.00

+37%

-21,832,850.00

+125%

-30,207,770.00

+38%

-39,163,120.00

+30%

-38,857,226.00

-1%

Operating Income Ratio (-33.13%) (0.00%) (-17.05%) (-61.42%) (-2.90%) (-7.82%) (-1.58%) (-2.12%) (-8.58%) (-6.95%) (-6.07%) (-5,530.65%) (-1.54%) (-201.57%) (0.00%) (-4.05%) (-7.10%) (-1.88%) (-2.48%) (-1.76%)
Other Income and Exp...
Interest Income 111.29k 231.82k 201.63k 306.26k 104.42k 91.66k 112.52k 161.55k 73.78k 86.48k 75.32k 178.68k 75.86k 114.88k 117.96k 207.03k 108.50k 24.43k 81.85k 795.98k
Interest Expenses 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 42.92k 38.82k 32.60k 27.29k 49.21k
Total Other Income/Exp... 153.60k 254.25k 807.10k 1.09M -788,346.00 91.66k 112.52k 161.55k 73.78k 133.72k -74,894.00 -94,941.00 78.34k 6.64M 118.21k 226.61k -2,942,539.00 -8,170.00 -15,731,828.00 -16,812,547.00
EBITDA
EBITDA -1,698,617.00 -3,592,387.00 -4,669,495.00 -5,524,338.00 -3,588,544.00 -4,597,542.00 -3,563,153.00 -3,869,772.00 -5,044,693.00 -4,921,882.00 -4,821,043.00 -6,102,483.00 -4,196,351.00 -9,638,389.00 -6,971,545.00 -8,885,209.00 -21,039,838.00 -29,394,686.00 -38,253,399.00 -38,117,552.00
EBITDA ratio (-32.32%) (0.00%) (-16.96%) (-60.87%) (-2.11%) (-7.71%) (-1.51%) (-2.02%) (-8.19%) (-6.66%) (-5.81%) (-5,417.16%) (-1.52%) (-199.89%) (0.00%) (-3.82%) (-6.90%) (-1.83%) (-2.42%) (-1.73%)
Income Before Tax
Income Before Tax -1,587,323.00 -4,277,488.00 -3,888,673.00 -4,483,938.00 -4,490,920.00 -4,572,825.00 -3,605,169.00 -3,904,524.00 -5,318,862.00 -5,049,660.00 -4,957,959.00 -6,045,920.00 -4,175,741.00 -9,604,811.00 -6,983,888.00 -9,475,245.00 -21,701,019.00 -30,266,789.00 -39,162,736.00 -55,669,773.00
Income Before Tax Ratio (-30.20%) (0.00%) (-14.12%) (-49.41%) (-3.52%) (-7.67%) (-1.53%) (-2.04%) (-7.47%) (-6.83%) (-5.98%) (-5,618.88%) (-1.51%) (-198.20%) (0.00%) (-3.96%) (-7.06%) (-1.89%) (-2.48%) (-2.52%)
Income Tax Expense
Income Tax Expense -1,587,323.00 -286,013.00 -201,628.00 -306,256.00 788.35k 0.00 0.00 0.00 -1,879,238.00 1.79M 1.97M -2,067,248.00 2.22M -2,170,814.00 -2,904,120.00 -2,395,706.00 -3,071,018.00 -15,972,821.00 -15,806,256.00 -17,559,314.00
Net Income
Net Income -1,587,323.00

+0%

-3,991,475.00

+151%

-3,888,673.00

-3%

-4,483,938.00

+15%

-4,490,920.00

+0%

-4,572,825.00

+2%

-3,605,169.00

-21%

-3,904,524.00

+8%

-3,439,624.00

-12%

-3,257,695.00

-5%

-2,991,479.00

-8%

-3,978,672.00

+33%

-1,950,837.00

-51%

-7,433,997.00

+281%

-4,079,767.00

-45%

-6,822,215.00

+67%

-17,767,586.00

+160%

-13,863,159.00

-22%

-22,788,985.00

+64%

-37,725,411.00

+66%

Net Income Ratio (-30.20%) (0.00%) (-14.12%) (-49.41%) (-3.52%) (-7.67%) (-1.53%) (-2.04%) (-4.83%) (-4.41%) (-3.61%) (-3,697.65%) (-0.71%) (-153.40%) (0.00%) (-2.85%) (-5.78%) (-0.86%) (-1.44%) (-1.71%)
Earning Per Share
Basic EPS 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.01 0.00 -0.01 -0.01
Diluted EPS 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.01 0.00 -0.01 -0.01
Share Outstanding
Basic Share Outstanding 2.80B 2.80B 2.80B 2.80B 2.80B 2.80B 2.80B 2.80B 2.80B 2.80B 2.80B 1.96B 2.80B 2.22B 2.80B 2.80B 3.13B 3.22B 3.25B 3.93B
Diluted Share Outstanding 2.80B 2.80B 2.80B 2.80B 2.80B 2.80B 2.80B 2.80B 2.80B 2.80B 2.80B 1.96B 2.80B 2.22B 2.80B 2.80B 3.13B 3.22B 3.25B 3.94B
8 New Orders
close
Theme Customizer

Customize your theme

close

Theme variation